Day: June 13, 2019

0
by in ,

PTS, Inc. Announces New Department for Enhanced Customer Service and Support

PTS, Inc. Announces New Department for Enhanced Customer Service and Support

Indianapolis, IN – July 6, 2012 – Polymer Technology Systems, Inc. (PTS, Inc.), the manufacturer of the CardioChek family of products, today announced the formation of a new department that will focus on customer service, technical support, customer training, internal product surveillance, complaint investigations, and the management of field evaluations and data. Known as the Regulatory and Clinical Affairs department, the group will also oversee proficiency testing and CRMLN certification.

The initiative to enhance customer service and support gained momentum when Elsa Chi Abruzzo joined PTS, Inc. on April 16, 2012 as Vice President of Regulatory and Clinical Affairs. Before coming to PTS, Inc., she was President and CEO of Abruzzo Regulatory Affairs Consulting (ARAC) in Cincinnati, Ohio. Her company was engaged in strategic regulatory, clinical, and quality consulting for the medical device, biologic, and pharmaceutical industry. Abruzzo has a successful track record spanning 23+ years with innovative medical devices and disruptive biotechnologies; has designed, developed and managed domestic and international clinical trials; and has implemented global regulatory strategies resulting in commercialization of products in the USA and worldwide.

Leading the Clinical Affairs group at PTS, Inc. will be Michelle Evans as Director of Clinical Affairs, with Bob Murphy managing the Midwest to East Coast region and Chris Campbell managing the Midwest to West Coast region. Ryan Jesswein, who is based in Indianapolis, will assist Evans with complaint investigations, technical support calls, customer training, internal product surveillance, and field evaluations, as well as domestic and international data management. The PTS, Inc. Customer Service department will also report to Evans.

“The establishment of a Clinical Affairs department consolidates our resources and highlights our commitment for customer service and support,” said Evans. “We want to make it easier for our customers to move from the point of sale to full utilization of all we have to offer, from training and field evaluations to tech support, and our Clinical Affairs department is designed to do just that.”

Jack Rogers, based in Indianapolis, has joined the company as Director of Regulatory Affairs, also reporting to Elsa Abruzzo.

Robert Huffstodt, President and CEO of PTS, Inc., said, “It’s great to have Elsa Abruzzo on board. She understands the importance of reliably and consistently providing our customers with exceptional products and services. Putting this Clinical Affairs team in place greatly enhances our ability to meet our customers’ needs, as our sales are growing quite dramatically. Jack Rogers rounds out the team nicely, and brings yet another dimension and skill set to our global business model.”

About Polymer Technology Systems, Inc.
Polymer Technology Systems, Inc. (PTS, Inc.) is a global provider of point-of-care diagnostic products to the healthcare industry. Headquartered in Indianapolis, Indiana, PTS, Inc. manufactures products for distribution in over 100 countries around the world. The company has sales offices in Africa, Australia, Europe, Latin America, the Middle East, and the Pacific Rim. PTS, Inc. products include the CardioChek® PA point-of-care instrument and the CardioChek® cholesterol analyzer that are marketed to the professional diagnostics industry and consumer screening market. The company offers lipid panel, LDL cholesterol, glucose, ketone, and other combination test strips for professional use with the CardioChek PA point-of-care instrument and the CardioChek Health Risk Assessment (HRA) software. For more information, visit www.cardiochek.com.

0
by in

CardioChek Test System Accepted by HEART UK for Use in Nationwide Program​

CardioChek Test System Accepted by HEART UK for Use in Nationwide Program

Indianapolis, IN – September 20, 2012 – Polymer Technology Systems, Inc. (PTS, Inc.), the U.S.-based manufacturer of the CardioChek family of point-of-care diagnostic products, announced today that HEART UK has accepted CardioChek as a point-of-care system for lipid testing in a nationwide health screening program. HEART UK, the United Kingdom’s (cholesterol) charity, works with the public and healthcare professionals to promote healthier lifestyles. HEART UK’s acceptance of CardioChek as a screening tool is a significant milestone, as PTS continues to expand its presence in global markets.

The CardioChek test system provides on-site lipid panel screening tests and delivers readings for total cholesterol, HDL cholesterol, triglycerides, LDL (calculated), and glucose in less than two minutes. CardioChek is represented in the UK by BHR Pharmaceuticals Ltd., a specialty distributor of point-of-care medical diagnostics.

Andrew Greaves, Sales Director for BHR, said he is delighted that HEART UK has approved CardioChek as a screening tool in the national “Health-Check” program, and he is confident that HEART UK’s acknowledgment will generate great interest within primary care organizations. Greaves continued, “As the Department of Health (UK) positions for greater awareness of the ‘Health-Check’ program, the drive to reduce the incidence of heart disease, and the need for reliable lipid testing in primary care, grows.”

Robert Huffstodt, President and CEO of PTS, Inc. said, “We are honored by this important acknowledgement by HEART UK. Their organization is very much respected for the work they do in cholesterol awareness and testing, and HEART UK’s recognition of the CardioChek system as a useful point-of-care screening tool is significant to our organization. With HEART UK’s dedication to healthcare and our proficiency in providing fast, reliable test results, I am confident our partnership will effectively detect and help to moderate the risk factors for heart disease in the United Kingdom.”

About HEART UK
HEART UK is registered as a charity with the Charity Commission (registered charity number 1003904) and as a company limited by guarantee with the Registrar of Companies (registered company number 02631049). HEART UK is an acronym, standing for Hyperlipidemia, Education, Atherosclerosis, and Research Trust UK. Visit the website at www.heartuk.org.uk.

About BHR Pharmaceuticals, LTD
BHR Pharmaceuticals Limited specializes in point-of-care (POC) medical diagnostics in six major fields; allergy, cardiovascular, diabetes, female health, gastro-intestinal and hematology. BHR works with the leading diagnostic manufacturers of the world to bring quality products to the UK market. The products and services offered by BHR have proven to be of great value to healthcare teams. With active support from BHR, PCT’s, GP’s and pharmacies achieve service framework objectives in a meaningful, timely and cost-effective manner. Visit the website at www.bhr.co.uk.

About Polymer Technology Systems, Inc. (PTS, Inc.)
Polymer Technology Systems, Inc. (PTS, Inc.) is a global provider of point-of-care diagnostic products to the healthcare industry. Headquartered in Indianapolis, Indiana, PTS, Inc. manufactures products for distribution in over 120 countries around the world. The company has sales offices in Europe, Latin America, and the Pacific Rim.

PTS, Inc. products include the CardioChek® PA point-of-care device and the CardioChek Health Risk Assessment (HRA) software, that are marketed to the professional diagnostics industry and the consumer screening market. The company offers tests for a Lipid Panel, LDL Cholesterol, Glucose, Ketone, and other single and combination test strips for professional use with the CardioChek point-of-care device. Visit the website at www.cardiochek.com.

For further information, please contact:
Kathleen Sutton
Director of Marketing
Polymer Technology Systems, Inc.
Indianapolis, IN
317-870-5610

All trademarks used or mentioned in this release are protected by law.

HEART UK LIT 001564 Rev. 0 9-12
0
by in

PTS, Inc. Announces Two New Patents

PTS, Inc. Announces Two New Patents

Indianapolis, IN – July 10, 2013- Polymer Technology Systems, Inc. (PTS, Inc.), the U.S.-based manufacturer of the CardioChek® family of point-of-care diagnostic products, has announced the issuance of two new U.S. patents. U.S. Patent No. 8,257,654 relates to the management of health data collected by point-of-care testing devices using a health report server. U.S. Patent No. 8,307,531 covers a method and apparatus for manufacturing disposable dry test strips.

“Our products are built upon a number of proprietary technologies and processes,” says Robert Huffstodt, President and CEO of PTS, Inc. “These patents, along with the other patents we hold, help PTS, Inc. maintain technological leadership for our customers.”

U.S. Patent No. 8,257,654 is for a health report server that may receive medical data from a diverse set of point-of-care testing systems deployed in a hospital or other medical facility. By utilizing a network-based system, medical data can be collected concerning patients and then securely and conveniently stored. The system allows for medical data to then be distributed to those medical personnel who need it, such as doctors. The system provides for simple menu-driven access to the stored medical information.

PTS, Inc. has led the way in providing innovative connectivity solutions. For example, the CardioChek HRA software captures biometric data and receives test results directly from a CardioChek PA analyzer to calculate a cardiac age based on an individual’s risk factors using the Framingham Heart Study criteria. And, CardioChek Link® data transfer software and cable provides for the output of test results from the CardioChek PA device into a computer spreadsheet file.

The intellectual property covered under U.S. Patent No. 8,307,531 not only provides for a more accurate test strip, but also reduces any waste and provides a more efficient manufacturing process.

The new patents are in addition to more than forty-five U.S. and international patents already owned by PTS, Inc. These patents span such technology areas as vertical flow HDL determination, room-temperature-stable triglycerides, structures and techniques for creating multi-analyte test strips, data collection and management from point-of-care testing devices, the detection of various cholesterol-related blood analytes, and other test strip-related detection technologies.

About Polymer Technology Systems, Inc. (PTS, Inc.) – Polymer Technology Systems, Inc. is a global provider of point-of-care diagnostic products to the healthcare industry.  Headquartered in Indianapolis, Indiana, PTS, Inc. designs, manufactures, and markets products for distribution in over 120 countries around the world. The company has sales offices in Europe, Latin America, and the Pacific Rim. PTS, Inc. products include the CardioChek PA point-of-care instrument which is marketed to the professional diagnostics industry, and the CardioChek cholesterol analyzer for consumer use. The company offers a variety of single and combination tests for lipids (cholesterols), Glucose, and Ketone, as well as the CardioChek Health Risk Assessment (HRA) software package. For more information, visit www.cardiochek.com.

For further information, please contact:
Laura Wilkerson
Director of Marketing
Polymer Technology Systems, Inc.
7736 Zionsville Road
Indianapolis, IN 46268
317-870-5610

All trademarks used or mentioned in this release are protected by law.

LIT 001581 Rev. 0 06/13
0
by in

PTS, Inc. Acquires A1CNow and Expands Product Portfolio

PTS, Inc. Acquires A1CNow and Expands Product Portfolio

Indianapolis, IN – December 20, 2013- Polymer Technology Systems, Inc. (PTS, Inc.), the U.S. based manufacturer of the CardioChek family of Point-of-Care diagnostic products, announced today that it has acquired the A1CNow family of products from Bayer Diabetes Care. The A1CNow+® Multi-test A1C System and A1CNow® SELFCHECK At-Home A1C System are important testing devices for readily monitoring A1C levels. The tests provide healthcare providers and people with diabetes with an indicator of the patient’s average blood glucose control over approximately the past 3 months.

“We’re very excited about the addition of the A1CNow system to the PTS product portfolio,” says Robert Huffstodt, President and CEO of PTS, Inc. “There is an established relationship between A1c levels, lipid levels and the risk for complications of diabetes, and the A1CNow products are important tools in helping providers and patients understand how well their diabetes treatment plan is working.”

The A1CNow acquisition strengthens the PTS product portfolio by adding testing capabilities that are being requested by many current PTS customers. The A1CNow system’s rapid results and mobility features enable healthcare providers to communicate face-to-face with patients about their diabetes control thus, providing optimum Point-of-Care convenience.

“We believe this acquisition is good news for PTS customers and A1CNow customers alike,” explains Huffstodt. “We’re eager to begin providing A1CNow systems to our global markets as soon as possible to help deliver vital information for healthcare providers and people with diabetes around the world.” Manufacturing will continue at the current plant in Sunnyvale, CA and product availability details will be forthcoming.

About Polymer Technology Systems, Inc. (PTS, Inc.) – Polymer Technology Systems, Inc. is a global provider of point-of-care diagnostic products to the healthcare industry. Headquartered in Indianapolis, Indiana, PTS, Inc. designs, manufactures, and markets products for distribution in over 120 countries around the world. The company has sales offices in Europe, Latin America and the Pacific Rim. PTS, Inc. products include the CardioChek PA Point-of-Care instrument which is marketed to the professional diagnostics industry, the CardioChek cholesterol analyzer for consumer use, and now the new CardioChek Plus analyzer. The company offers a variety of single and combination tests for lipids (cholesterols), glucose, and ketones as well as the CardioChek Health Risk Assessment (HRA) software package. For more information, visit www.cardiochek.com. For further information, please contact:

Laura Wilkerson
Director of Marketing
Polymer Technology Systems, Inc.
7736 Zionsville Road
Indianapolis, IN 46268
317-870-5610

All trademarks used or mentioned in this release are protected by law.

SOURCE Polymer Technology Systems, Inc.
LIT 001610 Rev. 0 12/13
0
by in

PTS Diagnostics Now Shipping A1CNow®+ Systems

PTS Diagnostics Now Shipping A1CNow®+ Systems

Indianapolis, IN – May 6, 2014- PTS Diagnostics, the U.S.-based manufacturer of both the CardioChek® brand and the A1CNow family of point-of-care diagnostic products, announced today that they have started shipping A1CNow+ systems to their distributor network. Just four months ago, PTS Diagnostics acquired the A1CNow family of products from Bayer Diabetes Care.

“A1CNow systems are important to healthcare providers and patients worldwide,” said Robert Huffstodt, President and CEO of PTS Diagnostics. “So, it was critical for us to facilitate a seamless transition and deliver the products in a timely manner.”

Ben Irvin, Director of A1CNow Research and Development, was a member of the team that developed the original A1CNow system in the early 2000s. “All of us in Sunnyvale, CA, are excited to be part of PTS Diagnostics. Their expertise in diagnostic device manufacturing, scientific knowhow, and established distribution network make this affiliation a perfect fit for the A1CNow family of products. We are also pleased that we were able to retain over 50 of our key people and that manufacturing and development will continue at the current plant in Sunnyvale.”

Not only did PTS Diagnostics acquire a high-quality and well-known product family, the company also purchased a proven manufacturing facility and is pleased to also employ so many associates that have a deep institutional knowledge of the A1CNow technology.

“We are delighted to welcome these former Bayer A1CNow employees and their customers to the PTS Diagnostics family. This has been an extraordinarily fast and easy transition. We are proud to be shipping product this quickly,” Huffstodt continued. “We know there is significant pent-up demand for the A1CNow+, and are pleased to be able to provide product without further delay.”

A1CNow+ empowers healthcare professionals to provide individuals with an indicator of average blood glucose control for the past 2 to 3 months.

About PTS Diagnostics – PTS Diagnostics is a global provider of point-of-care diagnostic products to the healthcare industry. Headquartered in Indianapolis, Indiana, PTS Diagnostics designs, manufactures, and markets products for distribution in over 120 countries around the world. The company has sales offices in Europe, Latin America, and the Pacific Rim. PTS Diagnostics’ products include the CardioChek systems and A1CNow point-of-care systems. The company also offers a variety of single and combination tests for lipids (cholesterols), glucose, and ketones, as well as the CardioChek Health Risk Assessment (HRA) software package. For more information, visit www.ptsdiagnostics.com or contact Laura Wilkerson at 317-870-5610.

All trademarks used or mentioned in this release are protected by law.

MKG001345 Rev. 0 03/15